Clinical Trials Directory

Trials / Conditions / Drug-Induced Liver Injury

Drug-Induced Liver Injury

49 registered clinical trials studyying Drug-Induced Liver Injury10 currently recruiting.

StatusTrialSponsorPhase
Not Yet RecruitingA Real World Study of Polyene Phosphatidylcholine Injection for the Prevention and Treatment of DILI in Patien
NCT07476885
Institute of Hematology & Blood Diseases Hospital, China
Not Yet RecruitingComparison of the Outcome of Treatment With Silymarin or N-Aceylcysteine in Patients Taking Anti-Tuberculous D
NCT07058090
Liaquat National Hospital & Medical CollegePhase 1
RecruitingDrug-induced Liver Injury: Itching Study
NCT06446609
University of Nottingham
RecruitingGlucocorticoids for Acute Drug Induced Liver Injury With Hyperbilirubinemia
NCT06922669
General Hospital of Shenyang Military RegionN/A
Not Yet RecruitingEfficacy of Plasmapheresis in Patients of Drug-Induced Liver Injury (DILI) With Underlying Chronic Liver Disea
NCT06797011
Institute of Liver and Biliary Sciences, IndiaPhase 2 / Phase 3
Active Not RecruitingRole of N-Acetylcysteine in Non-Acetaminophen-Induced Acute Liver Failure
NCT06872372
Lahore General HospitalN/A
CompletedClinical Study to Evaluate Cannabidiol Liver Enzyme Elevations and Drug Interactions
NCT06192589
Food and Drug Administration (FDA)Phase 1
UnknownA Randomized,Double-blind, Placebo Controlled, Multicenter Study to Evaluate the Safety and Efficacy of MT2004
NCT06019936
Xi'An Aolitai Pharmaceutical Technology Co LtdPhase 2
RecruitingProspective Comparative Validation Study of RUCAM and RECAM
NCT06771011
Beijing Friendship Hospital
TerminatedEvaluation of the Efficacy of Fomepizole in the Treatment of Acetaminophen Overdose
NCT05517668
Richard Dart, MD, PhDPhase 2
UnknownEfficacy of N-acetylcysteine to Prevent Anti-tuberculosis Drug-induced Liver Injury: A Randomized Controlled T
NCT05738681
Mahidol UniversityPhase 2 / Phase 3
UnknownAlterations of Gut Microbiota and Serum Biochemical Markers in DILI Patients
NCT05465642
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
CompletedDiscrimination of DILI and AIH by Artificial Intelligence
NCT05532345
Beijing Friendship Hospital
RecruitingA Prognostic Model for Drug-induced Liver Injury in China
NCT05060289
Beijing Friendship Hospital
CompletedRemaxol® in Patients With Drug-induced Liver Injuries During Cancer Chemotherapy
NCT05789797
POLYSAN Scientific & Technological Pharmaceutical Company
CompletedImpact of Silymarin Dosages to Decrease Drug-induced Elevated Liver Enzymes Compared to Placebo
NCT05144217
Prof. Dr. Frank BehrensPhase 2 / Phase 3
UnknownCombi-elastography Assessment of Chronic Liver Disease Multi-center Study
NCT04625166
Chinese PLA General Hospital
RecruitingScreening of Susceptibility Genes for APAP Induced Drug Induced LIver Injury in ChiNese Population: a Case-con
NCT04964310
The First Affiliated Hospital with Nanjing Medical University
UnknownGlucocorticosteroid Therapy on Drug-induced Liver Injury: a Prospective Non-randomized Concurrent Control Tria
NCT04553003
Li YangPhase 4
UnknownCorrelative Cohort Study on the Clinical Features and Prognosis of Drug-induced Liver Injury
NCT04302506
Beijing Ditan Hospital
TerminatedA Multicenter Observational Study on Safety of the Herbal Medicines at Inpatient Setting
NCT04269486
Korea Institute of Oriental Medicine
CompletedImmune Responses in Hepatocellular Carcinoma Patients After Treatment With Direct Acting Antiviral Drugs
NCT03602703
Assiut University
CompletedA Pharamcogenomic Study for Isoniazid According to NAT2 Polymorphism Status
NCT03665402
Seoul National University HospitalN/A
CompletedLeukotriene A4 Hydrolase Stratified Trial of Adjunctive Corticosteroids for HIV-uninfected Adults With Tubercu
NCT03100786
Oxford University Clinical Research Unit, VietnamPhase 3
CompletedAdjunctive Corticosteroids for Tuberculous Meningitis in HIV-infected Adults (The ACT HIV Trial)
NCT03092817
Oxford University Clinical Research Unit, VietnamPhase 3
CompletedAssessing Antibiotic Induced Liver Injury for Stratification of Tuberculosis Patients
NCT03211208
University of Edinburgh
UnknownSurveillance for Early Liver Injuries Caused by Yangxue Shengfa Capsule.
NCT03113838
Beijing 302 Hospital
UnknownSurveillance for Early Liver Injuries Caused by Xianlin Gubao Pill.
NCT03091556
Beijing 302 Hospital
UnknownSurveillance for Early Liver Injuries Caused by Runzao Zhiyang Capsule.
NCT03091218
Beijing 302 Hospital
UnknownSurveillance for Early Liver Injuries Caused by Xianlin Gubao Granule
NCT03091608
Beijing 302 Hospital
UnknownSurveillance for Early Liver Injuries Caused by Zhuanggu Guanjie Pill
NCT03060252
Beijing 302 Hospital
UnknownSurveillance for Early Liver Injuries Caused by Xianlin Gubao Capsule.
NCT03091244
Beijing 302 Hospital
UnknownComparative Study of Circulating microRNA Changes in Patients With Liver Injury and Healthy Subjects
NCT03000621
University of Electronic Science and Technology of China
RecruitingA Prospective Cohort Study on Drug-induced Liver Injury in China(DILI-P)
NCT02961413
Drug Induced Liver Disease Study Group
TerminatedEfficacy of N-acetylcysteine With or Without Steroids in Drug Induced Liver Injury
NCT02686385
Institute of Liver and Biliary Sciences, IndiaN/A
CompletedA Retrospective Study on Drug Induced Liver Injury in China
NCT02407964
Drug Induced Liver Disease Study Group
CompletedA Trial Of Intravenous N-Acetylcysteine In The Management Of Antituberculous Drug-Induced Hepatitis
NCT02182167
University of Cape TownPhase 2 / Phase 3
UnknownEstablishment of Drug-induced Liver Injury Databases and Application of Circulating microRNA(miRNA)
NCT02061826
Beijing Ditan Hospital
CompletedPreliminary Evaluation of a Point-Of-Care Liver Function Test
NCT01705041
PATHN/A
CompletedRechallenge, Potential Drug Induced Liver Injury (Kaiser)
NCT01584765
GlaxoSmithKline
TerminatedUltrasound Method to Measure Fibrosis of the Liver in Children
NCT02086708
Massachusetts General HospitalN/A
CompletedSonoelastography: Ultrasound Method to Measure Liver Fibrosis
NCT01747772
Massachusetts General HospitalN/A
CompletedIdentifying Changes in Blood (Potential Biomarkers) in Individuals With Drug-Induced Liver Injury
NCT01000766
University of North Carolina, Chapel Hill
WithdrawnAcetaminophen in Combination With N-Acetylcysteine (NAC) Versus Placebo in Treating Fever
NCT01137591
Columbia UniversityN/A
CompletedEfficacy and Safety Study of Magnesium Isoglycyrrhizinate Injection in Subjects With Acute Drug-induced Liver
NCT02734966
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Phase 2
CompletedAcetaminophen Adduct Formation in Non-Drinkers Taking Therapeutic Doses of Acetaminophen for Ten Consecutive D
NCT00616018
Kennon HeardPhase 4
CompletedLiver Enzyme Abnormalities and Risk Factors in Taking Herbal Medicine
NCT02299739
Jaseng Hospital of Korean Medicine
RecruitingDrug-Induced Liver Injury (DILI) Network Retrospective
NCT00360646
Duke University
CompletedRisk of Acute Liver Injury in Users of Antimicrobials
NCT01434173
Bayer